374Water Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that 374Water Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $215.0K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $445.4K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $744.0K | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $3.02M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $48.1K | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $86.6K | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $24.0K | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | $190.1K | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | $852.4K | Mar 29, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $852.4K | Apr 17, 2018 |
| FY2017 | Dec 31, 2016 | $587.6K | Apr 17, 2018 |
| FY2016 | Dec 31, 2015 | $529.9K | Apr 17, 2017 |
| FY2015 | Dec 31, 2014 | $428.7K | Oct 20, 2016 |
| FY2014 | Dec 31, 2013 | $359.4K | Mar 16, 2015 |
| FY2013 | Dec 31, 2012 | $193.7K | Mar 17, 2014 |
| FY2012 | Dec 31, 2011 | $193.4K | May 16, 2013 |
| FY2011 | Dec 31, 2010 | $33.8K | Apr 16, 2012 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($2.35M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($912.7K) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($1.11M) | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $336.5K | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $48.1K | Mar 16, 2023 |
| FY2015 | Dec 31, 2015 | $529.7K | Oct 20, 2016 |
| FY2015 | Dec 31, 2014 | $428.7K | Oct 20, 2016 |
| FY2014 | Dec 31, 2013 | $359.4K | Mar 16, 2015 |
| FY2013 | Dec 31, 2012 | $193.7K | Mar 17, 2014 |
| FY2012 | Dec 31, 2011 | $56.5K | May 16, 2013 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($20.98M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($12.43M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($8.10M) | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | ($4.69M) | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | ($3.16M) | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $40.3K | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | ($514.9K) | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | ($679.1K) | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | $404.4K | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | ($123.8K) | Apr 17, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($21.15M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($12.80M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($8.64M) | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | ($4.76M) | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | ($3.17M) | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | ($11.7K) | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | ($412.4K) | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | ($680.0K) | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | $431.3K | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | ($61.5K) | Apr 17, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.52M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $2.14M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $1.50M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $1.11M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $375.0K | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $57.7K | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $218.9K | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | $630.7K | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | $210.6K | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $331.0K | Apr 17, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($14.33M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($10.59M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($9.03M) | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | ($4.95M) | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | ($1.84M) | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $64.8K | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | ($287.4K) | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | $157.1K | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | $271.6K | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | ($146.8K) | Apr 17, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.90M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $554.9K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $106.0K | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $144.6K | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $1.2K | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $0 | Mar 1, 2022 |
| FY2015 | Dec 31, 2014 | $13.6K | Oct 20, 2016 |
| FY2014 | Dec 31, 2013 | ($57.7K) | Mar 16, 2015 |
| FY2012 | Dec 31, 2012 | $36.3K | May 16, 2013 |
| FY2012 | Dec 31, 2011 | $11.2K | May 16, 2013 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.41M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $19.18M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $16.12M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $9.92M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $12.41M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $103.8K | Mar 1, 2022 |
| FY2019 | Dec 31, 2019 | $37.5K | Apr 14, 2020 |
| FY2019 | Dec 31, 2018 | $104.2K | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | $508.8K | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $363.2K | Apr 17, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.68M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $3.71M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $1.37M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $1.66M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $86.4K | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $92.6K | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $407.4K | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | $39.1K | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | $245.3K | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $504.1K | Apr 17, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.72M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $15.47M | Mar 31, 2026 |
| FY2025 | Dec 31, 2023 | $14.75M | Mar 31, 2026 |
| FY2024 | Dec 31, 2022 | $8.25M | Mar 28, 2025 |
| FY2023 | Dec 31, 2021 | $12.33M | Mar 29, 2024 |
| FY2022 | Dec 31, 2020 | $11.3K | Mar 16, 2023 |
| FY2021 | Dec 31, 2019 | ($35.7K) | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $65.0K | Apr 13, 2021 |
| FY2019 | Dec 31, 2017 | $263.5K | Apr 14, 2020 |
| FY2018 | Dec 31, 2016 | ($140.9K) | Mar 29, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Dec 31, 2012 | $0 | May 16, 2013 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($49.94M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($28.39M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($15.95M) | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | ($7.85M) | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | ($3.16M) | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $4.6K | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | ($12.57M) | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | ($12.06M) | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | ($11.38M) | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | ($11.78M) | Apr 17, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $10.65M | Mar 28, 2025 |
| FY2024 | Dec 31, 2023 | $10.45M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $4.05M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $11.13M | Mar 16, 2023 |
| FY2020 | Dec 31, 2020 | $95.4K | Apr 13, 2021 |
| FY2020 | Dec 31, 2019 | $20.0K | Apr 13, 2021 |
| FY2020 | Dec 31, 2018 | $8.5K | Apr 13, 2021 |
| FY2019 | Dec 31, 2017 | $1.3K | Apr 14, 2020 |
| FY2018 | Dec 31, 2016 | $4.8K | Mar 29, 2019 |
| FY2017 | Dec 31, 2015 | $5.6K | Apr 17, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $306.3K | Apr 14, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 28, 2025 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 17.14M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 14.13M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 132.67M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | 126.70M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | 125.32M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | 62.41M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | 31.75M | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | 31.75M | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | 31.75M | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | 31.75M | Apr 17, 2018 |